Fungal infection prevention after hematopoietic cell transplantation

Bone Marrow Transplantation

Volumn 44, Issue 8, 2009, Pages 483-487

  Marr, K A ^a   Bow, E ^b   Chiller, T ^c   Maschmeyer, G ^d   Ribaud, P ^e   Segal, B ^f   Steinbach, W ^g   Wingard, J R ^h   Nucci, M ⁱ  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MANITOBA   (Canada)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d KLINIKUM ERNST VON BERGMANN   (Germany)

^e SAINT LOUIS HOSPITAL   (France)

^f ROSWELL PARK CANCER INSTITUTE   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF FLORIDA   (United States)

ⁱ FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CLOTRIMAZOLE; CYCLODEXTRIN; ECHINOCANDIN; FLUCONAZOLE; GROWTH FACTOR; ITRACONAZOLE; MICAFUNGIN; NYSTATIN; POSACONAZOLE; VORICONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLOSIS; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CANDIDIASIS; CLINICAL TRIAL; COUGHING; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG TOLERABILITY; EARLY DIAGNOSIS; ENVIRONMENTAL EXPOSURE; FOOD DEPRIVATION; FOOD DRUG INTERACTION; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HAND WASHING; HOSPITAL INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; INVASIVE CANDIDIASIS; LEUKEMIA; LOW DRUG DOSE; LUNG ASPERGILLOSIS; MOULD; MUCOSA INFLAMMATION; MYCOSIS; NEUTROPENIA; PRIORITY JOURNAL; RISK REDUCTION; UNSPECIFIED SIDE EFFECT;

ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL AGENTS; FOOD; FOOD MICROBIOLOGY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MYCOSES;

EID: 70350787236     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.259     Document Type: Article

References (0)